US6127356A
(en)
|
1993-10-15 |
2000-10-03 |
Duke University |
Oxidant scavengers
|
US6214817B1
(en)
*
|
1997-06-20 |
2001-04-10 |
Monsanto Company |
Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
|
US20050171198A1
(en)
*
|
1997-06-20 |
2005-08-04 |
Metaphore Pharmaceuticals, Inc. |
SODm therapy for treatment, prevention, inhibition and reversal of inflammatory disease
|
US20060270639A1
(en)
*
|
1997-06-20 |
2006-11-30 |
Daniela Salvemini |
Combinations of superoxide dismutase mimetics and nonsteroidal analgesic/anti-inflammatory drugs
|
CA2309154C
(en)
|
1997-11-03 |
2010-02-16 |
Duke University |
Substituted porphyrins
|
EP1616869B1
(en)
|
1999-01-25 |
2012-04-04 |
National Jewish Health |
Substituted porphyrins and their therapeutic use
|
DE60018925T2
(de)
|
1999-05-27 |
2006-04-13 |
Pharmacia Corp.(N.D.Ges.D.Staates Delaware) |
Biomaterialien, modifiziert mit superoxid-dismutase imitatoren
|
US20030069281A1
(en)
*
|
2000-06-14 |
2003-04-10 |
Irwin Fridovich |
Tetrapyrroles
|
US20020072512A1
(en)
*
|
2000-12-08 |
2002-06-13 |
Metaphore Pharmaceuticals, Inc |
Method of preventing and treating HIV-mediated central nervous system damage
|
DE60235955D1
(de)
*
|
2001-01-05 |
2010-05-27 |
Metaphore Pharmaceuticals Inc |
Zusammensetzungen und verfahren zur erhöhung der zytokin-aktivität und zur behandlung der hypotension assoziiert mit der verabreichung von zytokinen
|
CA2436245C
(en)
|
2001-01-19 |
2013-04-23 |
National Jewish Medical And Research Center |
Medicament for protection in radiotherapy
|
AU2002236861A1
(en)
*
|
2001-01-26 |
2002-08-06 |
Metaphore Pharmaceuticals, Inc. |
Method of treatment of neurodegenerative disorders using pentaaza-macrocyclic ligand complexes
|
US20040137638A1
(en)
|
2002-03-04 |
2004-07-15 |
Slomczynska Urszula J. |
Chromatography of metal complexes
|
WO2002071054A1
(en)
*
|
2001-03-02 |
2002-09-12 |
Metaphore Pharmaceuticals, Inc. |
Chromatography of metal complexes
|
EP1439842A4
(en)
*
|
2001-06-01 |
2009-09-02 |
Nat Jewish Med & Res Center |
OXIDANT CAPTAIN FOR THE TREATMENT OF DIABETES OR FOR THE USE IN THE TRANSPLANTATION OR INDUCTION OF IMMUNOTOLERANE
|
JP2005518334A
(ja)
*
|
2001-06-08 |
2005-06-23 |
メタファー・ファーマシューティカルズ・インコーポレイテッド |
コンホーメーション的に束縛されたペプチド、キラルアザクラウンおよびペプチド模倣物のライブラリーならびにその製造方法
|
MXPA03011795A
(es)
*
|
2001-06-26 |
2005-10-18 |
Metaphore Pharmaceuticals Inc |
Terapia de combinacion de una superoxido dismutasa mimetica y un corticosteroide para la prevencion y/o el tratamiento de una enfermedad inflamatoria.
|
US20030125347A1
(en)
*
|
2001-11-02 |
2003-07-03 |
Elan Corporation Plc |
Pharmaceutical composition
|
CN101092432A
(zh)
*
|
2001-12-14 |
2007-12-26 |
艾尔科公司 |
治疗眼睛障碍和疾病的超氧化物歧化酶模拟物
|
US6933275B2
(en)
*
|
2002-05-01 |
2005-08-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Protein kinase C peptides for use in withdrawal
|
US7485721B2
(en)
*
|
2002-06-07 |
2009-02-03 |
Duke University |
Substituted porphyrins
|
US20030232784A1
(en)
*
|
2002-06-14 |
2003-12-18 |
Benedict James J. |
Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain
|
CA2397684A1
(en)
*
|
2002-08-12 |
2004-02-12 |
Michael P. Murphy |
Mitochondrially targeted antioxidants
|
JP5189242B2
(ja)
*
|
2002-09-23 |
2013-04-24 |
アルケルメス ファーマ アイルランド リミテッド |
乱用抵抗性の医薬組成物
|
MXPA05005937A
(es)
*
|
2002-12-06 |
2005-08-18 |
Alcon Inc |
Imitaciones de superoxido de dismutasa para el tratamiento de trastornos y enfermedades oculares.
|
AU2003298917A1
(en)
*
|
2002-12-06 |
2004-06-30 |
Alcon, Inc. |
Superoxide dismutase mimics for the treatment of ocular disorders and diseases
|
KR100648618B1
(ko)
*
|
2003-11-19 |
2006-11-23 |
주식회사 웰스킨 |
활성 산소 억제제
|
AU2004305531B2
(en)
*
|
2003-12-11 |
2009-11-26 |
Alcon, Inc. |
Superoxide dismutase mimics for the treatment of optic nerve and retinal damage
|
WO2006069326A2
(en)
*
|
2004-12-21 |
2006-06-29 |
Metaphore Pharmaceuticals, Inc. |
Polyethylene glycolated superoxide dismutase mimetics
|
US20120301403A1
(en)
|
2007-06-21 |
2012-11-29 |
Galera Therapeutics, Llc |
Polyethylene glycolated superoxide dismutase mimetics
|
US8217166B2
(en)
*
|
2005-05-05 |
2012-07-10 |
Galera Therapeutics, Llc |
Polyethylene glycolated superoxide dismutase mimetics
|
KR100724586B1
(ko)
|
2005-12-09 |
2007-06-04 |
세종대학교산학협력단 |
수퍼옥사이드 디스뮤타아제 활성을 갖는 고리화합물
|
DK2056675T3
(en)
|
2006-10-12 |
2019-04-23 |
Galera Labs Llc |
Methods for treating oral mucositis
|
WO2009065059A2
(en)
*
|
2007-11-14 |
2009-05-22 |
Kereos, Inc. |
Super-oxide dismutase mimetics
|
ES2530462T3
(es)
|
2008-05-22 |
2015-03-03 |
Galera Therapeutics Llc |
Combinación terapia antitumoral
|
US11382895B2
(en)
|
2008-05-23 |
2022-07-12 |
National Jewish Health |
Methods for treating injury associated with exposure to an alkylating species
|
US9149483B2
(en)
|
2011-09-26 |
2015-10-06 |
Galera Labs, Llc |
Methods for treatment of diseases
|
CN108350009B
(zh)
|
2015-08-11 |
2021-07-09 |
加莱拉实验室有限责任公司 |
具有口服生物利用率的五氮杂大环状环络合物
|
US20210361701A1
(en)
*
|
2017-02-15 |
2021-11-25 |
Galera Labs, Llc |
Pentaaza macrocyclic ring complexes for local delivery
|
EP3388082A1
(en)
|
2017-04-13 |
2018-10-17 |
Galera Labs, LLC |
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
IL269915B
(en)
|
2017-04-13 |
2022-09-01 |
Galera Labs Llc |
Cancer immunotherapy combined with a macrocyclic ring pentase complex
|
CA3090129A1
(en)
|
2018-01-31 |
2019-08-08 |
Galera Labs, Llc |
Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent
|
EP4103573A1
(en)
|
2020-02-13 |
2022-12-21 |
Teva Pharmaceuticals International GmbH |
Solid state forms of avasopasem manganese and process for preparation thereof
|